Key companies and manufacturers are making heavy investments in sustainable packaging due to increasing environmental concerns across the globe. Apart from this, manufacturers are making heavy investments in R&D activities for the purpose of addressing the most important recycling challenges. Rapidly increasing investments in healthcare infrastructure has been contributing significantly towards the growth of pharmaceutical packaging market across the globe. Significant solution have been developed by the key companies and manufacturers for the purpose of handling the revenue loss occurred due to the counterfeiting practices.
Report on pharmaceutical packaging market was studied by the analysts of a research firm. The all-inclusive study helped analysts in revealing valuable information regarding the worldwide pharmaceutical packaging market. Analysts have viewed that pharmaceutical packaging market is expected to develop at an approximately 5.9% CAGR during the forecast period, 2017-2027. In addition, the pharmaceutical packaging market will be reaching an evaluation of nearly US$ 120.5Bn by the end of 2027.
Key companies operating in the pharmaceutical packaging market are inclusive of Gerresheimer AG, Bemis Company, Inc., Clondalkin Group Holdings B.V., Mondi Plc, ACG Pharmapack Pvt. Ltd., Ardagh Group S.A., Becton, Dickinson and Company and Schott AG. Other existing and emerging players in the pharmaceutical packaging market have been focusing on untapped regions and are taking heavy efforts for introducing advanced and effective pharmaceutical packaging across the globe. Developing new pharmaceutical packaging is likely to contribute towards business expansion as well as increasing customer-base.
Schott AG with ARaymond Life & Vanrx Pharmasystems Develop Innovative Packaging for Sterile Injectables
Key companies and manufacturers can take into account the point that ARaymond Life and Schott AG are combining their developments, thereby transforming it as the Product Set for usage with the Aseptic Filling Workcells of Vanrx Pharmasystems. Integration of ARaymondlife RayDyLyo® plastic press-fit closures and SCHOTT adaptiQ® vials with Aseptic Filling Workcells makes it completely commercially available as well as RTU (ready-to-use) along with closure reliability performance outcomes available from suppliers. The notable point is that this compatibility testing was carried out in order to provide pre-validated closure solutions for working on Aseptic Filling Workcells of Vanrx Pharmasystems.
The focal point here is that this Product Set will offer pharmaceutical companies with assurance with regards to high-performance for the sterile injectables. Drugs can be moved to the market faster, thereby creating flexible manufacturing operations utilizing the press-fit closures and nested and pre-sterilized RTU vials along with integrated stoppers combining with robotic aseptic filling system of Vanrx Pharmasystems.
Gerresheimer AG Acquires Sensile Medical
Key companies and manufacturers can take into account the point that Gerresheimer AG is planning to acquire Sensile Medical for the purpose of significantly expanding its business offerings. Sensile Medical will witness new opportunities as well as synergies along with prevailing and potential emerging customers. Both the companies together will work towards enhancing the Drug Delivery offering of Gerresheimer AG for its Biotech and Pharmaceutical partners, in particular, with its new electronic and digital capabilities.
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6150